AZN - AstraZeneca's Q3 revenue rose 7% to $16.2B, ahead of estimates, as oncology grew 17%
So what
Oncology sales rose 17% at constant currency to $7.77B, while cardio-renal fell 18% to $2.64B.
Full-size download: part of Free Access (free). The sheet above stays free to view and share.
Free Access
One free signup opens full-size downloads of every sheet and the pre-earnings pack for each earnings week. No newsletter schedule to sign up for.
Free Access is on: full-size downloads and the pre-earnings pack are open.